经鼻高流量氧疗提升间质性肺疾病运动耐量:随机交叉试验
结果显示高流量加氧较高流量显著延长运动时间91.5 s,单纯高流量未显著改善运动耐量但可提高运动期SpO2。
要点
- 高流量加氧(FiO2 0.6)可显著延长ILD患者恒负载运动时间。
- 单纯提高气体流量(40 L/min)未显著改善运动耐量。
- 高流量加氧使静息及运动期SpO2均显著升高。
核心结论
- 在ILD患者中,经鼻高流量联合氧疗可改善运动耐量与SpO2,单纯气流增加未改善运动耐量。
研究设计与样本
- 三种条件:室内空气(0 L/min,FiO2 0.21)、单纯高流量(40 L/min,FiO2 0.21)、高流量加氧(40 L/min,FiO2 0.6)。
- 主要终点为80%峰值功率下恒负载踏车运动的耐力时间。
主要发现
- 室内空气与单纯高流量间运动时间增加46.3 s(95%CI -6.1至98.7;p=0.083)。
- 单纯高流量与高流量加氧间运动时间增加91.5 s(95%CI 39.1至143.9;p<0.001)。
- 高流量加氧的静息SpO2显著高于室内空气与单纯高流量,差异持续至运动期。
- 运动等时点单纯高流量SpO2显著高于室内空气。
临床怎么用
- 对运动诱发低氧的ILD患者,可考虑高流量联合氧疗以延长运动耐受时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Interstitial lung disease (ILD) is characterized by dyspnoea on exertion and exercise-induced hypoxaemia. High-flow nasal cannula (HFNC) therapy reduces the respiratory workload through higher gas flow and oxygen supplementation, which may affect exercise tolerance. This study aimed to examine the effects of oxygen and gas flow rates through HFNC therapy on exercise tolerance in ILD patients. METHODS: We conducted three-treatment crossover study. All ILD patients performed the exercises on room air (ROOM AIR setting: flow, 0 L/min; fraction of inspired oxygen [FiO2], 0.21), HFNC (FLOW setting: flow 40 L/min, FiO2 0.21), and HFNC with oxygen supplementation (FLOW + OXYGEN setting: flow 40 L/min, FiO2 0.6). The primary endpoint was the endurance time, measured using constant-load cycle ergometry exercise testing at a peak work rate of 80%. RESULTS: Twenty-five participants (10 men, 71.2 ± 6.7 years) were enrolled. The increase in exercise duration between the ROOM AIR and FLOW was 46.3 s (95% CI, -6.1 to 98.7; p = 0.083), and the FLOW and FLOW + OXYGEN was 91.5 s (39.1-143.9; p < 0.001). The percutaneous oxygen saturation (SpO2) at rest was significantly higher with the FLOW + OXYGEN setting than with the ROOM AIR and FLOW settings, and the difference persisted during exercise. At equivalent time points during exercise, the SpO2 with the FLOW setting was significantly higher than that with the ROOM AIR setting. CONCLUSION: Oxygen supplementation in HFNC therapy improved exercise tolerance and SpO2. We found that gas flow alone did not improve exercise tolerance, but improved SpO2 during exercise.
引用
- Yanagita Y, Arizono S, Yokomura K, et al. Enhancing exercise tolerance in interstitial lung disease with high-flow nasal cannula oxygen therapy: A randomized crossover trial. Respirology. 2024. PMID: 38387607. doi:10.1111/resp.14684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。